4-Amino-2-piperidinone | CAS:5513-66-6
4-Amino-2-piperidinone
- 名称:4-氨基-2-哌啶酮 | 4-Amino-2-piperidinone
- CAS号:5513-66-6
- 别名:
- 分子式:C5H10N2O
- 分子量:114.15
- EINESC号:
产品描述
物理化学性质
没有数据 | 没有数据 |
---|
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
Matrix | 浏览或下载 |
产品合成路线
更多
名称 | CAS号 |
---|
更多
文章
同行评议文献
Disruption of diphthamide synthesis genes and resulting toxin resistance as a robust technology for quantifying and optimizing CRISPR/Cas9-mediated gene editing.Tobias Killian et al.Scientific reports, 7(1), 15480-15480 (2017-11-15)
Control of the Restriction Point by Rb and p21.Justin Moser et al.Proceedings of the National Academy of Sciences of the United States of America, 115(35), E8219-E8227 (2018-08-17)
Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining.Takeshi Maruyama et al.Nature biotechnology, 33(5), 538-542 (2015-03-24)
Repurposing of KLF5 activates a cell cycle signature during the progression from a precursor state to oesophageal adenocarcinoma.Connor Rogerson et al.eLife, 9 (2020-09-04)
Enrichment of G2/M cell cycle phase in human pluripotent stem cells enhances HDR-mediated gene repair with customizable endonucleases.Diane Yang et al.Scientific reports, 6, 21264-21264 (2016-02-19)
Disruption of diphthamide synthesis genes and resulting toxin resistance as a robust technology for quantifying and optimizing CRISPR/Cas9-mediated gene editing.Killian T, et al. Scientific Reports, 7(1), 15480-15480 (2017)
An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression.Mrinal Srivastava et al.Cell, 151(7), 1474-1487 (2012-12-25)
Increasing the efficiency of CRISPR/Cas9-mediated precise genome editing in rats by inhibiting NHEJ and using Cas9 protein.Yuanwu Ma et al.RNA biology, 13(7), 605-612 (2016-05-11)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|
相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!